Iliacus Myositis and Bacteremia Caused by Non-typhoidal Salmonella in a Healthy Adult: A Case Report
Abstract
Typically, non-typhoidal Salmonella (NTS) causes gastroenteritis; however, NTS can also lead to extraintestinal manifestations like bacteremia, meningitis, and abscess in vulnerable populations such as children, elderly, and immunocompromised individuals. Extraintestinal manifestations in an immunocompetent patient are uncommon. Here, we report a case of iliacus myositis and bacteremia caused by NTS in a healthy adult. A previously healthy 23-year-old Japanese woman presented to the emergency room due to a one-day history of vomiting, abdominal pain, and diarrhea. She had a fever, and her blood test showed leukocytosis. Computed tomography (CT) of the abdomen and pelvis revealed a thickening of the ascending colon. She was diagnosed with gastroenteritis and treated with antibiotics. Blood culture at that time was negative, but Salmonella serogroup 09 was detected in stool culture. Subsequently, her symptoms improved; however, on day 13, she returned to our hospital complaining of pain in her left thigh. CT scan of the abdomen and pelvis revealed no abscess or muscle inflammation, but due to persistent symptoms, the patient was admitted to the hospital, and antibiotics were initiated. Salmonella serogroup 09 was detected from the blood culture obtained at the time of admission. Magnetic resonance imaging of the hip joint and CT of the abdomen and pelvis after admission revealed inflammation in the left iliacus muscle and an abscess near the left ilium. The patient was treated…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.